News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or overweight.
Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Explore more
1d
News-Medical.Net on MSNWhich GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answersResearchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...
The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...
Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Tirzepatide, an injection medication already approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes, is likely to receive FDA approval for another indication — weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results